Comprehensive analysis of CBFβ-MYH11 fusion transcripts in acute myeloid leukemia by RT-PCR analysis

Journal of Molecular Diagnostics

Volumn 6, Issue 1, 2004, Pages 22-27

  Kadkol, ShriHari S ^a   Bruno, Annette ^a   Dodge, Carol ^a   Lindgren, Valerie ^a   Ravandi, Farhad ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORE BINDING FACTOR; MYOSIN HEAVY CHAIN; CBFBETA MYH11 FUSION PROTEIN; CBFBETA-MYH11 FUSION PROTEIN; ONCOPROTEIN; PRIMER DNA;

ACUTE GRANULOCYTIC LEUKEMIA; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; CASE REPORT; CHROMOSOME TRANSLOCATION 16; CONTROLLED STUDY; CYTOGENETICS; DIAGNOSTIC VALUE; FLUORESCENCE IN SITU HYBRIDIZATION; FOLLOW UP; FUSION GENE; GENE EXPRESSION; GENETIC ANALYSIS; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HUMAN TISSUE; MEDICAL DECISION MAKING; MOLECULAR PROBE; NUCLEOTIDE SEQUENCE; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TISSUE SECTION; TREATMENT OUTCOME; ALGORITHM; CHROMOSOME 16; CHROMOSOME BREAKAGE; DNA SEQUENCE; GENETICS; METHODOLOGY; PATHOLOGY; REPRODUCIBILITY; TUMOR CELL LINE;

ALGORITHMS; CELL LINE, TUMOR; CHROMOSOME BREAKAGE; CHROMOSOMES, HUMAN, PAIR 16; DNA PRIMERS; HUMANS; LEUKEMIA, MYELOCYTIC, ACUTE; ONCOGENE PROTEINS, FUSION; REPRODUCIBILITY OF RESULTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS, DNA;

EID: 1142275272     PISSN: 15251578     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1525-1578(10)60487-4     Document Type: Article

References (21)

1. Poirel H, Radford-Weiss I, Rack K, Troussard X, Veil A, Valensi F, Picard F, Guesnu M, Leboeuf D, Melle J, Dreyfus F, Flandrin G, Macintyre E: Detection of the chromosome 16 CBF β-MYH11 fusion transcript in myelomonocytic leukemias. Blood 1995, 85:1313-1322
2. Claxton DF, Liu P, Hsu HB, Marlton P, Hester J, Collins F, Deisseroth AB, Rowley JD, Siciliano MJ: Detection of fusion transcripts generated by the inversion 16 chromosome in acute myelogenous leukemia. Blood 1994, 83:1750-1756
3. Tobal K, Johnson PR, Saunders MJ, Harrison CJ, Liu Yin JA: Detection of CBFB/MYH11 transcripts in patients with inversion and other abnormalities of chromosome 16 at presentation and remission. Br J Haematol 1995, 91:104-108
4. van der Reijden BA, Lombardo M, Dauwerse HG, Giles RH, Muhlematter D, Bellomo MJ, Wessels HW, Beverstock GC, van Ommen GJ, Hagemeijer A, Breuning MH: RT-PCR diagnosis of patients with acute nonlymphocytic leukemia and inv(16)(p13q22) and identification of new alternative splicing in CBFB-MYH11 transcripts. Blood 1995, 86:277-282
5. Braess J, Jahns-Streubel G, Schoch C, Haase D, Haferlach T, Fiegl M, Voss S, Kern W, Schleyer E, Hiddemann W: Proliferative activity of leukaemic blasts and cytosine arabinoside pharmacodynamics are associated with cytogenetically defined prognostic subgroups in acute myeloid leukaemia. Br J Haematol 2001, 113:975-982
6. Bloomfield CD, Lawrence D, Byrd JC, Carroll A, Pettenati MJ, Tantravahi R, Patil SR, Davey FR, Berg DT, Schiffer CA, Arthur DC, Mayer RJ: Frequency of prolonged remission duration after high-dose cytarabine intensification in acute myeloid leukemia varies by cytogenetic subtype. Cancer Res 1998, 58:4173-4179
7. Hart SS, Foroni L: Core binding factor genes and human leukemia. Haematologica 2002, 87:1307-1323
8. Shurtleff SA, Meyers S, Hiebert SW, Raimondi SC, Head DR, Willman CL, Wolman S, Slovak ML, Carroll AJ, Behm F, Hulshof MG, Motroni TA, Okuda T, Liu P, Collins FS, Downing JR: Heterogeneity in CBF β/MYH11 fusion messages encoded by the inv(16)(p13q22) and the t(16;16)(p13;922) in acute myelogenous leukemia. Blood 1995, 85: 3695-3703
9. Kundu M, Javed A, Jeon JP, Horner A, Shum L, Eckhaus M, Muenke M, Lien JB, Yang Y, Nuckolls GH, Stein GS, Liu PP: Cbfβ interacts with Runx2 and has a critical role in bone development. Nat Genet 2002, 32:639-644
10. Miller JD, Stacy T, Liu PP, Speck NA: Core-binding factor β (CBFβ), but not CBFβ-smooth muscle myosin heavy chain, rescues definitive hematopoiesis in CBFβ-deficient embryonic stem cells. Blood 2001, 97:2248-2256
11. van der Reijden BA, de Wit L, van der Poel S, Luiten EB, Lafage-Pochitaloff M, Dastugue N, Gabert J, Lowenberg B, Jansen JH: Identification of a novel CBFB-MYH11 transcript: implications for RT-PCR diagnosis. Hematol J 2001, 2:206-209
12. Langabeer SE, Walker H, Gale RE, Wheatley K, Burnett AK, Goldstone AH, Linch DC: Frequency of CBF β/MYH11 fusion transcripts in patients entered into the UK MRC AML trials: The MRC Adult Leukaemia Working Party. Br J Haematol 1997, 96:736-739
13. Ritter M, Thiede C, Schakel U, Schmidt M, Alpen B, Pascheberg U, Mohr B, Ehninger G, Neubauer A: Underestimation of inversion (16) in acute myelold leukaemia using standard cytogenetics as compared with polymerase chain reaction: results of a prospective investigation. Br J Haematol 1997, 98:969-972
14. Rowe D, Cotterill SJ, Ross FM, Bunyan DJ, Vickers SJ, Bryon J, McMullan DJ, Griffiths MJ, Reilly JT, Vandenberghe EA, Wilson G, Wetmore AE, Bown NP: Cytogenetically cryptic AML1-ETO and CBF β-MYH11 gene rearrangements: incidence in 412 cases of acute myeloid leukaemia. Br J Haematol 2000, 111:1051-1056
15. Harth H, Pees H, Zankl H: Acute myelomonocytic leukemia (M4) with eosinophilia: problems concerning chromosome 16 abnormality. Cancer Genet Cytogenet 1986, 23:127-133
16. Ravandi F, Kadkol SS, Ridgeway J, Bruno A, Dodge C, Lindgren V: Molecular identification of CBFβ-MYH11 fusion transcripts in an AML M4Eo patient in the absence of inv16 or other abnormality by cytogenetic and FISH analyses: a rare occurrence. Leukemia 2003, 17: 1907-1910
17. Grimwade D, Walker H, Oliver F, Wheatley K, Harrison C, Harrison G, Rees J, Hann I, Stevens R, Burnett A, Goldstone A: The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukaemia Working Parties. Blood 1998, 92:2322-2333
18. Mitterbauer M, Laczika K, Novel M, Mitterbauer G, Hilgarth B, Pirc-Danoewinata H, Schwarzinger H, Haas OA, Fonatsch C, Lechner K, Jaeger U: High concordance of karyotype analysis and RT-PCR for CBF β/MYH11 in unselected patients with acute myeloid leukemia. Am J Pathol 2000, 113:406-410
19. Grardel N, Roumier C, Soenen V, Lai JL, Plantier I, Gheveart C, Cosson A, Fenaux P, Preudhomme C: Acute myeloblastic leukemia (AML) with inv (16)(p13;q22) and the rare I type CBFβ-MYH11 transcript: report of two new cases. Leukemia 2002, 16:150-151
20. Yanagisawa K, Horiuchi T, Fujita S: Establishment and characterization of a new human leukemia cell line derived from M4E0. Blood 1991, 78:451-457
21. Marcucci G, Caligiuri MA, Dohner H, Archer KJ, Schlenk RF, Dohner K, Maghraby EA, Bloomfield CD: Quantification of CBFβ/MYH11 fusion transcript by real time RT-PCR in patients with INV(16) acute myeloid leukemia. Leukemia 2001, 15:1072-1080